SCHEMBL21610293

SCHEMBL21610293

CNOC(=O)Cc1ncc2ccccc2c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
NPC1 O15118 2/20 0.39
SMN1; SMN2 Q16637 6/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 3/20 0.36
HTT P42858 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PRNP P04156 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624730 0.81 SMN1; SMN2 (0.48) TDP1NPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL16624654 0.77 TDP1 (0.39) TDP1NPC1SMN1; SMN2L3MBTL1HPGD
SCHEMBL20799451 0.77 HPGD (0.46) TDP1ALDH1A1MAPTKDM4EHTT
SCHEMBL17954336 0.76 HPGD (0.44) TDP1ALDH1A1KDM4EHPGDCYP1A2
SCHEMBL21610292 0.76 ALDH1A1 (0.49) SMN1; SMN2L3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL22333840 0.73 DHFR (0.46) TDP1NPC1SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL20101392 0.73 TDP1 (0.36) TDP1NPC1SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL21610289 0.72 SMN1; SMN2 (0.70) TDP1NPC1SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL5808263 0.71 SMN1; SMN2 (0.38) TDP1NPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL21610291 0.70 PDE10A (0.40) NPC1SMN1; SMN2L3MBTL1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10519446-B2 Organic compounds to treat hepatitis B virus NOVARTIS AG (CH) 2019-12-31 US disclosed